Inner Workings: Lyme disease vaccines face familiar challenges, both societal and scientific [Immunology and Inflammation]

Just over 20 years ago, a Lyme disease vaccine called LYMErix was approved for sale in the United States. Researchers designed the vaccine to prevent the transmission of the tick-borne pathogen Borellia burgdorferi, which spurs a bacterial infection that can cause fever, headaches, and joint pain if left untreated. The...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Inner Workings, Front Matter Source Type: research